Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02529332 · ClinicalTrials.gov registry record · NA
Omega-3 Supplementation for Smell Dysfunction
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02529332: Completed NA study, sponsored by Stanford University.
NCT02529332 is a NA study that has completed, run by Stanford University. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02529332, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Omega-3 supplementation has been shown to have neuroprotective and potentially anti-inflammatory properties in both central and peripheral nerve injuries. The investigators are studying to see if omega-3 supplementation will affect olfactory (smell) function in patients with olfactory dysfunction following endoscopic removal of pituitary tumors.
Interventions
- DIETARY_SUPPLEMENT Omega-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02529332
The ClinicalTrials.gov registry entry for NCT02529332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 is the first listed.
NCT02529332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02529332 about?
NCT02529332 is a clinical study titled "Omega-3 Supplementation for Smell Dysfunction". Omega-3 supplementation has been shown to have neuroprotective and potentially anti-inflammatory properties in both central and peripheral nerve injuries. The investigators are studying to see if omega-3 supplementation will affect olfactory (smell) function in patients with olfactory dysfunction fo...
What is the current status of trial NCT02529332?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2014-09. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02529332?
The interventions under investigation include: Omega-3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02529332?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.